Bard Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bard Financial Services's PFE Position: Q3 2025 in Review
Bard Financial Services increased its Pfizer (PFE) stake by 1.1% in Q3 2025, buying an estimated $141K and bringing the position to 510,321 shares worth $13M. The position accounts for 1.43% of the portfolio, ranked #13.
Bard Financial Services first reported a position in PFE in Q4 2020 and has held it in 20 quarters since. The position peaked at $16.7M in Q4 2021. 2,817 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Bard Financial Services held 510,321 shares of Pfizer worth $13M as of Q3 2025.
- Bard Financial Services bought 5,716 Pfizer shares in Q3 2025, an estimated $141K.
- Pfizer made up 1.43% of Bard Financial Services's portfolio in Q3 2025, its #13 holding.
- Bard Financial Services first reported a position in Pfizer in Q4 2020 and has held it in 20 quarters since.
- Bard Financial Services's Pfizer position peaked at $16.7M in Q4 2021.
- 2,817 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Bard Financial Services's 13F filing for Q3 2025, filed 17 Oct 2025.